BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37537110)

  • 1. Diagnostic Accuracy of Biomarkers and International Ovarian Tumor Analysis Simple Rules in Diagnosis of Ovarian Cancer.
    Haliti TI; Hoxha I; Mojsiu R; Mandal R; Goç G; Hoti KD
    Hematol Oncol Clin North Am; 2024 Feb; 38(1):251-265. PubMed ID: 37537110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the diagnostic accuracy of International Ovarian Tumor Analysis simple rules and the risk of malignancy index to discriminate between benign and malignant adnexal masses.
    Auekitrungrueng R; Tinnangwattana D; Tantipalakorn C; Charoenratana C; Lerthiranwong T; Wanapirak C; Tongsong T
    Int J Gynaecol Obstet; 2019 Sep; 146(3):364-369. PubMed ID: 31206642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective external validation of IOTA three-step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two-step strategy using simple-rules risk.
    Hidalgo JJ; Ros F; Aubá M; Errasti T; Olartecoechea B; Ruiz-Zambrana Á; Alcázar JL
    Ultrasound Obstet Gynecol; 2019 May; 53(5):693-700. PubMed ID: 30353585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
    Hiett AK; Sonek JD; Guy M; Reid TJ
    Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses.
    Di Legge A; Testa AC; Ameye L; Van Calster B; Lissoni AA; Leone FP; Savelli L; Franchi D; Czekierdowski A; Trio D; Van Holsbeke C; Ferrazzi E; Scambia G; Timmerman D; Valentin L
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):345-54. PubMed ID: 22611001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses.
    Xie WT; Wang YQ; Xiang ZS; Du ZS; Huang SX; Chen YJ; Tang LN
    J Ovarian Res; 2022 Jan; 15(1):15. PubMed ID: 35067220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation of IOTA simple descriptors and simple rules for classifying adnexal masses.
    Alcázar JL; Pascual MA; Graupera B; Aubá M; Errasti T; Olartecoechea B; Ruiz-Zambrana A; Hereter L; Ajossa S; Guerriero S
    Ultrasound Obstet Gynecol; 2016 Sep; 48(3):397-402. PubMed ID: 26748432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of International Ovarian Tumor Analysis Simple Rules to Society of Radiologists in Ultrasound Guidelines for Detection of Malignancy in Adnexal Cysts.
    Patel-Lippmann KK; Sadowski EA; Robbins JB; Paroder V; Barroilhet L; Maddox E; McMahon T; Sampene E; Wasnik AP; Blaty AD; Maturen KE
    AJR Am J Roentgenol; 2020 Mar; 214(3):694-700. PubMed ID: 31770022
    [No Abstract]   [Full Text] [Related]  

  • 9. Ultrasonographic diagnosis of adnexal masses: interobserver agreement in the interpretation of videos, using IOTA terminology.
    Massobrio R; Mariani LL; Conti D; De Grandis T; Buonomo F; Badellino E; Novara L; Bounous VE; Perotto S; Mancarella M; Ferrero A; Biglia N; Fuso L
    Arch Gynecol Obstet; 2024 Jan; 309(1):211-218. PubMed ID: 37789207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative diagnostic accuracy of the IOTA SRR and LR2 scoring systems for discriminating between malignant and Benign Adnexal masses by junior physicians in Chinese patients: a retrospective observational study.
    Tian C; Wen SB; Zhao CY; Yan XN; Du JX
    BMC Womens Health; 2023 Nov; 23(1):585. PubMed ID: 37940895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
    Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
    Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-Step Strategy for Optimizing the Preoperative Classification of Adnexal Masses in a University Hospital, Using International Ovarian Tumor Analysis Models: Simple Rules and Assessment of Different NEoplasias in the adneXa Model.
    Esquivel Villabona AL; Rodríguez JN; Ayala N; Buriticá C; Gómez AC; Velandia AM; Rodríguez N; Alcázar JL
    J Ultrasound Med; 2022 Feb; 41(2):471-482. PubMed ID: 33890698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of IOTA Simple Rules, IOTA ADNEX Model, RMI, and Subjective Assessment for Preoperative Adnexal Mass Evaluation: The Experience of a Tertiary Care Referral Hospital.
    Vilendecic Z; Radojevic M; Stefanovic K; Dotlic J; Likic Ladjevic I; Dugalic S; Stefanovic A
    Gynecol Obstet Invest; 2023; 88(2):116-122. PubMed ID: 36716716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center.
    Araujo KG; Jales RM; Pereira PN; Yoshida A; de Angelo Andrade L; Sarian LO; Derchain S
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):778-783. PubMed ID: 27194129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of IOTA simple rules for adnexal masses classification: a comparison between two centers with different ovarian cancer prevalence.
    Ruiz de Gauna B; Rodriguez D; Olartecoechea B; Aubá M; Jurado M; Gómez Roig MD; Alcázar JL
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():10-4. PubMed ID: 26066289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IOTA Simple Rules in Differentiating between Benign and Malignant Adnexal Masses by Non-expert Examiners.
    Tinnangwattana D; Vichak-Ururote L; Tontivuthikul P; Charoenratana C; Lerthiranwong T; Tongsong T
    Asian Pac J Cancer Prev; 2015; 16(9):3835-8. PubMed ID: 25987045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of IOTA SR and O-RADS combined with CA125, HE4, and risk of malignancy algorithm to distinguish benign and malignant adnexal masses.
    Yang Y; Ju H; Huang Y
    Eur J Radiol; 2023 Aug; 165():110926. PubMed ID: 37418798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group.
    Timmerman D; Van Calster B; Testa A; Savelli L; Fischerova D; Froyman W; Wynants L; Van Holsbeke C; Epstein E; Franchi D; Kaijser J; Czekierdowski A; Guerriero S; Fruscio R; Leone FPG; Rossi A; Landolfo C; Vergote I; Bourne T; Valentin L
    Am J Obstet Gynecol; 2016 Apr; 214(4):424-437. PubMed ID: 26800772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis.
    Kaijser J; Sayasneh A; Van Hoorde K; Ghaem-Maghami S; Bourne T; Timmerman D; Van Calster B
    Hum Reprod Update; 2014; 20(3):449-62. PubMed ID: 24327552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective internal validation of mathematical models to predict malignancy in adnexal masses: results from the international ovarian tumor analysis study.
    Van Holsbeke C; Van Calster B; Testa AC; Domali E; Lu C; Van Huffel S; Valentin L; Timmerman D
    Clin Cancer Res; 2009 Jan; 15(2):684-91. PubMed ID: 19147775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.